Photographic Evaluation of Patients with Androgenetic Alopecia Treated with 1 mg of Finasteride (Propecia)

January 2003 in “ Piel ”

J.C. Moreno, José Manuel Fernández Vozmediano, Paloma Sánchez Pedreño

finasteride androgenetic alopecia photographic evaluation Propecia

Studysummary Photography is a simple and effective way to track hair loss treatment progress with finasteride.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study evaluated the use of photography as a simple method to monitor patients with androgenetic alopecia treated with 1 mg/day of finasteride, a drug with proven efficacy. The clinical evaluation of androgenetic alopecia was noted to be challenging and often subjective, with existing complex methods not accessible to all dermatologists. The study aimed to assess the practicality and effectiveness of photographic evaluation in providing a more objective measure of treatment progress in these patients.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Long-Term Multinational Experience with Finasteride 1 mg in the Treatment of Men with Androgenetic Alopecia

20 citations , April 2002 in “PubMed”

This study found that long-term treatment with finasteride 1 mg/day significantly improved scalp hair growth and was well tolerated in men with androgenetic alopecia over five years compared to placebo.

research Photographic Documentation of the Effectiveness of 1 mg Oral Finasteride in the Treatment of Androgenic Alopecia in Men in Routine General Practice in Switzerland

4 citations , November 2001 in “PubMed”

This study observed that 54% of men with male pattern hair loss showed hair growth improvement in the vertex region after 6 months of treatment with oral finasteride.

research Management of Androgenetic Alopecia

22 citations , May 2000 in “American Journal of Clinical Dermatology”

This review discusses treatment options for androgenetic alopecia in men and women, highlighting minoxidil and finasteride, without presenting new clinical findings.

research Treatment of Hair Loss

370 citations , September 1999 in “The New England Journal of Medicine”

This article discusses the treatment of androgenetic alopecia and alopecia areata with finasteride and minoxidil but reports no new clinical results.

research The Psychosocial Consequences of Androgenetic Alopecia: A Review of the Research Literature

180 citations , September 1999 in “British Journal of Dermatology”

This review discusses the psychological and social impacts of androgenetic alopecia and suggests that medical treatments can have some positive psychological effects, highlighting the condition's moderate stress and impact on body image.

research Novel Agents for the Treatment of Alopecia

29 citations , December 1998 in “Seminars in Cutaneous Medicine and Surgery”

This review examines recent approvals and emerging treatments for androgenetic alopecia, discussing newly approved drugs like Propecia and Rogaine Extra Strength 5%, but without presenting new clinical results.

research Hair Regrowth

118 citations , April 1998 in “Dermatologic Clinics”

This review discusses the advancements in understanding and treating androgenetic alopecia and alopecia areata but reports no clinical findings; the authors emphasize the need for further research on molecular control mechanisms.

Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia

research Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia

416 citations , September 1997 in “Journal of Investigative Dermatology”

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

research The 5 Alpha-Reductase System and Its Inhibitors

124 citations , January 1996 in “Dermatology”

This article reviews the biochemical properties of 5 alpha-reductase isoforms and highlights the limited dermatological use of inhibitors like finasteride, especially for type 1 isozyme-targeting agents, while suggesting further clinical exploration.